$ICUI

ICU MEDICAL INC/DE

CIK:0000883984|SEC Filings

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
REVENUES:
TOTAL REVENUES	$ 551,683	$ 548,866	$ 1,081,908	$ 1,153,568
Cost of goods sold	316,630	340,802	640,629	735,395
Gross Profit	235,053	208,064	441,279	418,173
OPERATING EXPENSES:
Selling, general and administrative	151,922	159,392	306,488	316,625
Research and development	22,702	21,867	43,982	45,158
Restructuring, strategic transaction and integration	21,302	16,218	38,103	32,915
TOTAL OPERATING EXPENSES	195,926	197,477	388,573	394,698
INCOME (LOSS) FROM OPERATIONS	39,127	10,587	52,706	23,475
Interest Expense,net	(15,747)	(20,549)	(32,241)	(42,580)
OTHER INCOME (EXPENSE), net	(236)	1,818	(1,296)	55
Gain on sale of business	0	41,823	0	41,823
Income (loss0 before income taxes and equity in earnings of unconsolidated affiliates	23,144	33,679	19,169	22,773
PROVISION FOR INCOME TAXES	(7,070)	(1,178)	27,644	(5,748)
NET INCOME (LOSS) FROM CONSOLIDATED COMPANIES	16,074	32,501	46,813	17,025
Equity in Earnings of Unconsolidated Affiliates	3,013	2,837	2,406	2,837
NET INCOME (LOSS)	$ 19,087	$ 35,338	$ 49,219	$ 19,862
NET INCOME (LOSS) PER SHARE
Basic (in dollars per share)	$ 0.76	$ 1.43	$ 1.98	$ 0.81
Diluted (in dollars per share)	$ 0.76	$ 1.43	$ 1.96	$ 0.80
WEIGHTED AVERAGE NUMBER OF SHARES
Basic (in shares)	25,000	24,645	24,884	24,593
Diluted (in shares)	25,044	24,708	25,132	24,746
Operating Segments
OPERATING EXPENSES:
Selling, general and administrative	$ 151,922	$ 159,392	$ 306,488	$ 316,625
Research and development	22,702	21,867	43,982	45,158
PROVISION FOR INCOME TAXES	(7,070)	(1,178)	27,644	(5,748)
Equity in Earnings of Unconsolidated Affiliates	$ (3,013)	$ (2,837)	$ (2,406)	$ (2,837)

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
NET INCOME (LOSS)	$ 49,219	$ 19,862
Depreciation and amortization	99,640	99,110
Noncash lease expense	8,136	9,308
Stock compensation	25,881	26,636
(Loss) gain on disposal of property and equipment	1,983	1,753
Debt Issuance Costs amortization	1,574	3,482
Equity in Earnings of Unconsolidated Affiliates	(2,406)	(2,837)
Other	13,471	8,037
Accounts receivable	(7,562)	16,691
Inventories	4,625	(29,213)
Prepaid expenses and other current assets	(16,461)	(9,208)
Other Assets	(2,936)	(5,682)
Accounts payable	(4,909)	14,382
Accrued liabilities	(5,895)	(19,835)
Income taxes, including excess tax benefits and deferred income taxes	(45,301)	(28,125)
Net cash provided by operating activities	119,059	62,538
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(29,813)	(34,317)
Proceeds from Sales of Business, Affiliate and Productive Assets	0	209,464
Deposit received for the sale of a business	2,000	0
Proceeds from sale of asset	22	42
Intangible assets additions	(3,555)	(4,541)
Net cash used in investing activities	(31,346)	170,648
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayments of Long-term Debt	54,688	247,750
Proceeds from exercise of stock options	490	5,972
Payments on finance leases	(1,297)	(885)
Payment, Tax Withholding, Share-based Payment Arrangement	38,862	8,688
Net cash used in by financing activities	(94,357)	(251,351)
Effect of Exchange Rate on Cash [Abstract]
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation	(3,020)	9,624
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(9,664)	(8,541)
Cash and Cash Equivalents	298,299	300,025
Supplemental Cash Flow Information [Abstract]
Income Taxes Paid	15,300	34,072
Interest Paid, Excluding Capitalized Interest, Operating Activity	34,606	44,414
NON-CASH INVESTING ACTIVITIES
Capital Expenditures Incurred but Not yet Paid	4,470	13,253
Transfer to Investments	$ 0	$ 125,826